SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000920465-14-000055
Filing Date
2014-07-08
Accepted
2014-07-08 18:35:16
Documents
1
Period of Report
2014-07-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_140485890483643.html 3  
1 FORM 3 wf-form3_140485890483643.xml 3 1648
  Complete submission text file 0000920465-14-000055.txt   3043
Mailing Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122
Business Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O A.P. PHARMA, INC., 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address
Rosen Robert (Reporting) CIK: 0001555089 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36282 | Film No.: 14966183